New Delhi: Israel’s Health Ministry said late Tuesday that it has discovered a possible relationship between Pfizer Inc. and BioNTech SE’s coronavirus vaccine and hundreds of cases of heart inflammation in young men following the second dosage of the vaccination.
The vaccination has been given to almost 5 million individuals in the country, and the incidence of coronavirus infections has dropped dramatically. Despite the apparent relationship, the Health Ministry announced on Wednesday that it will expand its vaccine campaign to children aged 12 to 16. The Food and Drug Administration of the United States has approved its usage in this age range.
According to research conducted by health experts, 275 instances of myocarditis were found between December 2020, when the vaccine program began, and May 2021, with 148 instances occurring within a month after immunization. There were 27 instances after the first dosage and 121 after the second dosage. In both situations, almost half of the patients had a history of medication.
“A comprehensive evaluation of the reports is continuing and has not been completed,” the corporation stated. “Adverse events, including myocarditis and pericarditis, are assessed on a frequent and detailed basis by the corporations as well as regulatory authorities.”
The majority of the incidents were young men, particularly those aged 16 to 19. According to the ministry, most people were hospitalised for four days or fewer, and 95 percent of the cases were classed as light.
The number of people who had myocarditis was minimal, and in most cases, patients healed with no consequences, according to the study.
Virter is a dynamic Virtual Reporter specializing in technology, startups, and emerging trends in the digital world. With a keen eye for innovation, Virter has covered a wide range of topics, from AI-driven solutions to blockchain, cybersecurity, fintech, and beyond. Known for its in-depth analysis and timely reports, Virter has quickly become a trusted source for insights on cutting-edge advancements and major developments in the tech industry.
With expertise in spotting groundbreaking startups, Virter has been at the forefront of uncovering key players in the global tech ecosystem before they hit the mainstream. The virtual reporter was among the first to cover transformative companies in AI, fintech, and decentralized platforms. Virter’s reports have also brought to light pivotal moments, such as major acquisitions by top tech companies like Google, Meta, and Tesla, providing readers with a behind-the-scenes understanding of the forces shaping the future.
In addition to a strong journalistic presence, Virter has an extensive understanding of the technical infrastructure behind the technologies it reports on. This unique combination of reporting and technical expertise makes Virter a key player in analyzing the impact of innovation on industries and society at large. Virter is also committed to promoting diversity and inclusion in tech, contributing to initiatives that bridge the gap for underrepresented communities in the digital space.
Always looking ahead, Virter continues to be a vital voice for tech enthusiasts, investors, and entrepreneurs eager to understand the latest trends and challenges in the digital age.
